Treatment of Right Knuckle Stiffness
Begin with joint protection education and a structured exercise regimen combining range-of-motion and strengthening exercises, which forms the foundation of treatment for all patients with hand osteoarthritis. 1
Initial Non-Pharmacological Management
The optimal approach requires combining non-pharmacological and pharmacological treatments tailored to the specific joint involved, severity of structural changes, and degree of functional impairment. 1
First-Line Physical Interventions
Implement range-of-motion and strengthening exercises immediately, as these are recommended for all patients with hand osteoarthritis regardless of severity. 1
Apply local heat therapy (paraffin wax or hot packs) before exercise sessions to enhance effectiveness, with heat application showing strong support (77% expert agreement). 1
Educate the patient on joint protection techniques to avoid adverse mechanical factors that perpetuate stiffness and pain. 1
Consider orthoses or splints if there is lateral angulation or flexion deformity developing at the knuckle, particularly for thumb base involvement. 1
Important caveat: Ultrasound therapy has minimal supporting evidence (0% expert agreement) and should not be prioritized despite being mentioned in guidelines. 1
Pharmacological Treatment Algorithm
Step 1: Topical Therapy (Preferred Initial Approach)
Start with topical NSAIDs or capsaicin as first-line pharmacological treatment, especially when only a few joints are affected with mild to moderate pain. 1
Topical treatments are preferred over systemic agents due to superior safety profile and effectiveness for localized hand osteoarthritis. 1
Step 2: Oral Analgesics
Prescribe acetaminophen (paracetamol) up to 4 g/day if topical treatments provide insufficient relief, as this is the oral analgesic of first choice based on efficacy and safety (87% strength of recommendation). 1
Continue acetaminophen as the preferred long-term oral analgesic if successful. 1
Step 3: Oral NSAIDs (If Acetaminophen Fails)
Use oral NSAIDs at the lowest effective dose for the shortest duration in patients responding inadequately to acetaminophen. 1
Re-evaluate periodically to assess continued need and response. 1
For patients with increased gastrointestinal risk: Add gastroprotective agent with non-selective NSAIDs, or use selective COX-2 inhibitor. 1
For patients with increased cardiovascular risk: COX-2 inhibitors are contraindicated; use non-selective NSAIDs with extreme caution. 1
Interventional Options for Refractory Cases
Corticosteroid Injections
Consider intra-articular long-acting corticosteroid injection for painful flares, particularly effective for trapeziometacarpal (thumb base) joint osteoarthritis. 1
This option is moderately recommended (60% strength) for acute inflammatory exacerbations. 1
Critical warning: Use corticosteroid injections cautiously, as they may inhibit healing and reduce tensile strength of periarticular tissues, potentially predisposing to complications. 1
Symptomatic Slow-Acting Drugs
Glucosamine, chondroitin sulfate, or other SYSADOAs may provide symptomatic benefit with low toxicity, but effect sizes are small and clinically relevant structure modification has not been established. 1
These agents have moderate recommendation strength (63%) and should be considered adjunctive rather than primary therapy. 1
Surgical Referral Criteria
Refer for surgical evaluation (interposition arthroplasty, osteotomy, or arthrodesis) when:
- Marked pain and/or disability persist despite comprehensive conservative treatment failure. 1
- Severe thumb base osteoarthritis with functional limitations affecting quality of life. 1
Surgery is moderately recommended (68% strength) for appropriately selected patients with severe disease. 1
Common Pitfalls to Avoid
Do not delay exercise therapy waiting for pain to fully resolve—exercise is therapeutic, not contraindicated, in stable hand osteoarthritis. 1
Do not use systemic NSAIDs as first-line when topical options are appropriate for localized involvement. 1
Do not continue ineffective treatments—reassess at 2-4 weeks and escalate therapy if no improvement occurs. 1
Do not overlook inflammatory arthritis in the differential diagnosis, which may present with similar stiffness but requires different management including potential DMARDs or biologics. 1